2019
DOI: 10.1080/01902148.2018.1563925
|View full text |Cite
|
Sign up to set email alerts
|

MiR-34c-5p plays a protective role in chronic obstructive pulmonary disease via targeting CCL22

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 50 publications
0
11
0
Order By: Relevance
“…Also, it has been reported that CCL22 can be targeted inhibited by miR-34c-5p in COPD, which contributes to the inflammatory response and the maintenance of protease antiprotein balance. 33 All the above studies showed the potential efficacy of CCL22 in various diseases. In our drug resistance study, DDP-resistant GC cells showed a high proliferation, and the apoptosis was not significantly improved under DDP intervention.…”
Section: Discussionmentioning
confidence: 91%
“…Also, it has been reported that CCL22 can be targeted inhibited by miR-34c-5p in COPD, which contributes to the inflammatory response and the maintenance of protease antiprotein balance. 33 All the above studies showed the potential efficacy of CCL22 in various diseases. In our drug resistance study, DDP-resistant GC cells showed a high proliferation, and the apoptosis was not significantly improved under DDP intervention.…”
Section: Discussionmentioning
confidence: 91%
“…miR-34c-5p was confirmed to be poorly expressed in lung adenocarcinoma in association with poor prognosis, setting a foundation for subsequent experiments. Importantly, miR-34c-5p has been acknowledged to be of great importance in lung-related diseases [16,17]. Besides, miR-34c-5p has been suggested as a target for potential therapeutic strategies in cancer pain management [18].…”
Section: Discussionmentioning
confidence: 99%
“…The suppressing effect of miR-34c-5p is necessary for embryo implantation during WOI. A series of studies have reported that miR-34c-5p involved the process of endometrial receptivity and inflammation [12,54]. An interesting study revealed that miR-34c-5p inhibited exosome release by targeting RAB27B, a molecule that promotes exosome shedding [34].…”
Section: Discussionmentioning
confidence: 99%